Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Citizens Financial Group Officer Reports Share Disposition

Matthew Boss, Head of Consumer Banking at Citizens Financial Group, filed a Form 4 on September 3, 2026, disclosing a disposition of common stock that occurred on September 1, 2026.

Shwetambri Chauhan | 03 September 2026

Methode Electronics CAO Disposes of 1,649 Shares in Tax Withholding

Stacie Schulz, Chief Accounting Officer of Methode Electronics Inc, filed a Form 4 on September 3, 2026, reporting the disposition of 1,649 shares of common stock on September 2, 2026, to satisfy tax obligations tied to the vesting of restricted stock units.

Nitish Kishor | 03 September 2026

ZoomInfo CFO Reports RSU Vesting and Share Withholding

ZoomInfo Technologies Inc. CFO Michael Graham O'Brien filed a Form 4 on September 3, 2026, disclosing restricted stock unit vesting transactions and a tax-related share withholding that occurred on September 1, 2026.

Shwetambri Chauhan | 03 September 2026

Beta Bionics CPO Sells Shares to Cover RSU Tax Withholding

Beta Bionics, Inc. (NASDAQ:BBNX) Chief Product Officer Mike Mensinger filed a Form 4 on September 3, 2026, reporting the sale of 4,375 shares of common stock on September 2, 2026, to cover tax withholding obligations tied to vesting restricted stock units.

Vinay Lochav | 03 September 2026

ICU Medical VP General Counsel Sells 4,856 Shares

Virginia Ruth Sanzone, VP and General Counsel of ICU Medical Inc/DE (NASDAQ:ICUI), filed a Form 4 on September 3, 2026, disclosing the sale of 4,856 shares of common stock across four transactions executed that same day under a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 03 September 2026

Beta Bionics CMO Sells Shares for Tax Withholding

Beta Bionics, Inc. Chief Medical Officer Steven Jon Russell filed a Form 4 on September 3, 2026, reporting the sale of common stock on September 2, 2026, to cover tax withholding obligations tied to the vesting of restricted stock units.

Shwetambri Chauhan | 03 September 2026

Beta Bionics CCO Sells Shares for Tax Withholding

Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), filed a Form 4 on September 3, 2026, disclosing the sale of 5,327 shares of common stock on September 2, 2026, to cover tax withholding obligations associated with the vesting of restricted stock units.

Aakashdeep | 03 September 2026

Bio-Rad Laboratories Chairman CEO Reports RSU Vesting

Norman D. Schwartz, Chairman and CEO of Bio-Rad Laboratories, Inc., filed a Form 4 on September 3, 2026, disclosing transactions in Bio-Rad Class A common stock on September 1, 2026, stemming from the vesting of restricted stock units.

Shwetambri Chauhan | 03 September 2026

Bio-Rad Laboratories Director Reports RSU Vesting

Allison Schwartz, a director of Bio-Rad Laboratories, Inc., filed a Form 4 on September 3, 2026, disclosing transactions in Bio-Rad Class A common stock on September 1, 2026, stemming from the vesting of restricted stock units.

Vinay Lochav | 03 September 2026

Bio-Rad Laboratories EVP James Barry RSU Vesting

James Barry, Executive Vice President and President of the Life Science Group at Bio-Rad Laboratories, Inc., filed a Form 4 on September 3, 2026, reporting restricted stock unit vestings and a related share withholding transaction dated September 1, 2026.

Aditi Sarkar | 03 September 2026
Support

Hi! How can we help you today?

Loading…